Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer

This study evaluated the SHURUI single-port (SP) robotic system for uniportal robotic-assisted thoracic surgery (RATS) in lung cancer patients. Unlike conventional multi-incision systems, the SHURUI SP utilizes a single, highly flexible robotic arm, aiming to improve maneuverability and minimize incision size, which is especially beneficial for patients with limited thoracic space. In a phase I/II trial, 35 patients (median age 58) underwent lobectomy or segmentectomy. All surgeries were completed successfully, with no need to switch to other surgical methods or make additional incisions. The median operative time was 155 minutes, with minimal blood loss and no transfusions required. The 30-day complication rate was low at 11.43 percent, with no major issues or readmissions, and patients were typically discharged after four days. Compared to the multiple fully jointed arms required for the da Vinci single-port, the SHURUI SP provides a potential single-port alternative.